Tao Mi

Ministry Of Education Key Laboratory Of Child Development And Disorders
Chongqing, 400014, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Dual metabolic intervention nanoplatform co-delivering BAY-876 and L-cystine for Wilms tumor therapy via disulfidptosis-associated cytoskeletal collapse.

Dual metabolic intervention nanoplatform co-delivering BAY-876 and L-cystine for Wilms tumor therapy via disulfidptosis-associated cytoskeletal collapse.

Journal: Journal of nanobiotechnology
Published: February 10, 2026

SNRPC promotes chemoresistance in Wilms tumor via the NF-κB-CXCL17 axis regulating M2-Type TAMs infiltration and targeted nanotherapy research.

SNRPC promotes chemoresistance in Wilms tumor via the NF-κB-CXCL17 axis regulating M2-Type TAMs infiltration and targeted nanotherapy research.

Journal: Journal of experimental & clinical cancer research : CR
Published: August 26, 2025

CD24-targeted cystine and glucose oxidase cascade catalytic nanosystem triggers disulfidptosis in neuroblastoma.

CD24-targeted cystine and glucose oxidase cascade catalytic nanosystem triggers disulfidptosis in neuroblastoma.

Journal: Materials today. Bio
Published: August 12, 2025

Targeting interferon regulatory factor 7 alleviates renal fibrosis by inhibiting macrophage-to-myofibroblast transition.

Targeting interferon regulatory factor 7 alleviates renal fibrosis by inhibiting macrophage-to-myofibroblast transition.

Journal: Life sciences
Published: March 18, 2025

The PI3K-AKT-mTOR signaling pathway mediates epithelial mesenchymal transition and cytoskeletal architecture changes induce to renal fibrosis after Bisphenol S exposure.

The PI3K-AKT-mTOR signaling pathway mediates epithelial mesenchymal transition and cytoskeletal architecture changes induce to renal fibrosis after Bisphenol S exposure.

Journal: Scientific reports
Published: January 09, 2025

NR2F6 promotes the malignant progression of neuroblastoma as an indicator of poor prognosis.

NR2F6 promotes the malignant progression of neuroblastoma as an indicator of poor prognosis.

Journal: PloS one
Published: August 31, 2024

ZSTK474 targeting PIK3R3 inhibits the Wilms' tumor through G0 / G1 phase arrest.

ZSTK474 targeting PIK3R3 inhibits the Wilms' tumor through G0 / G1 phase arrest.

Journal: PloS one
Published: July 05, 2024

CENPF May Act as a Novel Marker and Highlight the Influence of Pericyte in Infantile Hemangioma.

CENPF May Act as a Novel Marker and Highlight the Influence of Pericyte in Infantile Hemangioma.

Journal: Angiology
Published: June 20, 2024

Inducing disulfidptosis in tumors:potential pathways and significance.

Inducing disulfidptosis in tumors:potential pathways and significance.

Journal: MedComm
Published: June 05, 2024

Recruitment and polarization typing of tumor-associated macrophages is associated with tumor progression and poor prognosis in Wilms tumor patients.

Recruitment and polarization typing of tumor-associated macrophages is associated with tumor progression and poor prognosis in Wilms tumor patients.

Journal: PloS one
Published: April 12, 2024

Dual roles of HK3 in regulating the network between tumor cells and tumor-associated macrophages in neuroblastoma.

Dual roles of HK3 in regulating the network between tumor cells and tumor-associated macrophages in neuroblastoma.

Journal: Cancer immunology, immunotherapy : CII
Published: January 20, 2024

Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma.

Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma.

Journal: Journal of cancer research and clinical oncology
Published: January 09, 2024
Showing 1-12 of 41

Last Updated: 09/26/2026